Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of the ChAdox1 n CoV-19 Vaccine Against SARS-CoV-2 With 12-dose Vials: an Interim Analysis

NCT04961385 is registered in ClinicalTrials.gov with Bangkok Metropolitan Administration Medical College and Vajira Hospital as lead sponsor.

NCT NCT04961385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04961385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of the ChAdox1 n CoV-19 Vaccine Against SARS-CoV-2 With 12-dose Vials: an Interim Analysis
Lead sponsor
Bangkok Metropolitan Administration Medical College and Vajira Hospital
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
May 31, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, immunogenicity, vaccine